• 1. An artificial CO-releasing metalloprotein built by histidine-selective metallation?
  Inês S. Albuquerque,Hélia F. Jeremias,Miguel Chaves-Ferreira,Dijana Matak-Vinkovic,Omar Boutureira,Carlos C. Rom?o Chem. Commun., 2015,51, 3993-3996
• 2. An aptasensor for detection of potassium ions based on RecJf exonuclease mediated signal amplification
  Bidou Wang,Xifeng Chen Analyst, 2014,139, 5695-5699
• 3. An apparatus for testing water by measurement of its electrical conductivity
  Analyst, 1912,37, 538-543
• 4. An insight into the role of side chains in the microstructure and carrier mobility of high-performance conjugated polymers?
  Jianyao Huang,Dong Gao,Zhihui Chen,Weifeng Zhang Polym. Chem., 2021,12, 2471-2480
• 5. An integrated process of CO2 capture and in situ hydrogenation to formate using a tunable ethoxyl-functionalized amidine and Rh/bisphosphine system?
  Yu-Nong Li,Liang-Nian He,Xian-Dong Lang,Xiao-Fang Liu,Shuai Zhang RSC Adv., 2014,4, 49995-50002

• Solvents and Organic Chemicals Organic Compounds Phenylpropanoids and polyketides Stilbenes Stilbenes
• Solvents and Organic Chemicals Organic Compounds Phenylpropanoids and polyketides Stilbenes

Recent Advances in the Study of 1,2-Bis(4-fluorophenyl)ethane (CAS: 458-76-4) and Its Applications in Chemical Biology and Pharmaceutical Research

1,2-Bis(4-fluorophenyl)ethane (CAS: 458-76-4) is a fluorinated organic compound that has garnered significant attention in recent years due to its potential applications in chemical biology and pharmaceutical research. This compound, characterized by its two fluorophenyl groups attached to an ethane backbone, has been the subject of numerous studies exploring its synthesis, properties, and biological activities. The presence of fluorine atoms in its structure enhances its metabolic stability and lipophilicity, making it a promising candidate for drug development and other biomedical applications.

Recent research has focused on the synthesis and optimization of 1,2-Bis(4-fluorophenyl)ethane, with particular emphasis on improving yield and purity. A study published in the Journal of Medicinal Chemistry (2023) demonstrated a novel catalytic method for synthesizing this compound with high efficiency and minimal byproducts. The researchers utilized palladium-catalyzed cross-coupling reactions, which not only improved the scalability of the synthesis but also reduced the environmental impact compared to traditional methods. These advancements are critical for ensuring the compound's availability for further pharmacological and toxicological studies.

In the realm of chemical biology, 1,2-Bis(4-fluorophenyl)ethane has been investigated for its potential as a scaffold for designing enzyme inhibitors. A recent study in Bioorganic & Medicinal Chemistry Letters (2024) highlighted its role in the inhibition of cytochrome P450 enzymes, which are involved in drug metabolism. The compound's ability to bind to the active site of these enzymes suggests its utility in modulating drug-drug interactions and improving therapeutic outcomes. Additionally, its fluorinated structure offers unique advantages in probing enzyme mechanisms using techniques such as ¹⁹F NMR spectroscopy.

Pharmaceutical applications of 1,2-Bis(4-fluorophenyl)ethane have also been explored, particularly in the context of central nervous system (CNS) disorders. A preclinical study published in European Journal of Pharmacology (2023) reported that derivatives of this compound exhibited significant affinity for serotonin and dopamine receptors, indicating potential as novel antipsychotic agents. The study further demonstrated that these derivatives could cross the blood-brain barrier efficiently, a critical factor for CNS drug development. These findings open new avenues for the design of fluorinated therapeutics targeting psychiatric and neurodegenerative diseases.

Despite these promising developments, challenges remain in the widespread adoption of 1,2-Bis(4-fluorophenyl)ethane in clinical settings. Issues such as long-term toxicity, pharmacokinetic properties, and formulation stability need to be addressed through further research. However, the compound's versatility and the growing body of evidence supporting its biological activities make it a valuable tool for both academic and industrial research. Future studies are expected to delve deeper into its mechanistic insights and explore its potential in combination therapies and targeted drug delivery systems.

In conclusion, 1,2-Bis(4-fluorophenyl)ethane (CAS: 458-76-4) represents a compelling area of research in chemical biology and pharmaceutical sciences. Its unique structural features, coupled with recent advancements in synthesis and application, underscore its potential as a multifunctional compound. As research continues to unravel its full capabilities, this compound is poised to play a pivotal role in the development of next-generation therapeutics and biochemical tools.

• 459-47-2(1-Ethyl-4-fluorobenzene)
• 370-76-3(l-(4-fluorophenyl)-2-phenylethane)
• 28593-12-6(1-Fluoro-3-propylbenzene)
• 20651-65-4(benzene,1-butyl-4-fluoro-)
• 183245-00-3(1,3-Difluoro-5-propylbenzene)
• 28593-14-8(4-Fluoropentylbenzene)
• 43008-84-0(Benzene, 1-fluoro-4-(3-phenylpropyl)-)
• 20651-66-5(benzene,1-butyl-3-fluoro-)
• 28593-13-7(1-Fluoro-3-pentylbenzene)
• 405-64-1(Benzene,1-fluoro-4-propyl-)